日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial

手术可切除的促纤维增生性黑色素瘤新辅助PD-1阻断治疗:SWOG S1512 II期试验的A组队列

Kendra, Kari L; Bellasea, Shay L; Eroglu, Zeynep; Hu-Lieskovan, Siwen; Campbell, Katie M; Carson, William E 3rd; Wada, David A; Plaza, Jose A; In, Gino K; Ikeguchi, Alexandra; Hyngstrom, John; Brohl, Andrew S; Chmielowski, Bartosz; Khushalani, Nikhil I; Markowitz, Joseph; Monroe, Marcus; Contreras, Carlo M; Bowles, Tawnya; Norman, Kurt; Medina, Egmidio; Gonzalez, Cynthia R; Baselga-Carretero, Ignacio; Garcilazo, Ivan Perez; Vega-Crespo, Agustin; Chen, Jia Ming; Deen, Nataly Naser Al; Patel, Sapna P; Grossmann, Kenneth F; Sondak, Vernon K; Sharon, Elad; Moon, James; Wu, Michael C; Ribas, Antoni

Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial

抗PD-1疗法治疗不可切除的促纤维增生性黑色素瘤:SWOG S1512 II期试验

Kari L Kendra ,Shay L Bellasea ,Zeynep Eroglu ,Siwen Hu-Lieskovan ,Katie M Campbell ,William E Carson 3rd ,David A Wada ,Jose A Plaza ,Jeffrey A Sosman ,Gino K In ,Alexandra Ikeguchi ,John Hyngstrom ,Andrew S Brohl ,Nikhil I Khushalani ,Joseph Markowitz ,George Negrea ,Samer Kasbari ,Gary C Doolittle ,Umang Swami ,Toni Roberts ,Boban N Mathew ,Egmidio Medina ,Ignacio Baselga-Carretero ,Cynthia R Gonzalez ,Ivan Perez Garcilazo ,Agustin Vega-Crespo ,Jia Ming Chen ,Nataly Naser Al-Deen ,Sapna P Patel ,Elad Sharon ,James Moon ,Michael C Wu ,Antoni Ribas

Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny

通过转基因造血干细胞后代实现人类癌症靶向免疫

Theodore S Nowicki ,Nataly Naser Al Deen ,Cole W Peters ,Begoña Comin-Anduix ,Egmidio Medina ,Cristina Puig-Saus ,Ignacio Baselga Carretero ,Paula Kaplan-Lefko ,Mignonette H Macabali ,Ivan Perez Garcilazo ,Daniel Chen ,Jia Pang ,Beata Berent-Maoz ,Salem Haile ,Jonathan Rodriguez ,Moe Kawakami ,Conner K Kidd ,Ameya Champhekar ,Giuseppe Carlucci ,Agustin Vega-Crespo ,Bartosz Chmielowski ,Arun Singh ,Noah Federman ,Gary M Schiller ,Sarah J Larson ,Martin Allen-Auerbach ,Alexandra M Klomhaus ,Jerome Zack ,David Baltimore ,Lili Yang ,Donald B Kohn ,Owen N Witte ,Antoni Ribas

CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes

靶向TYRP1表面表达的CAR-T细胞疗法用于治疗皮肤黑色素瘤和罕见黑色素瘤亚型

Sameeha Jilani # ,Justin D Saco # ,Edurne Mugarza # ,Aleida Pujol-Morcillo ,Jeffrey Chokry ,Clement Ng ,Gabriel Abril-Rodriguez ,David Berger-Manerio ,Ami Pant ,Jane Hu ,Rubi Gupta ,Agustin Vega-Crespo ,Ignacio Baselga-Carretero ,Jia M Chen ,Daniel Sanghoon Shin ,Philip Scumpia ,Roxana A Radu ,Yvonne Chen ,Antoni Ribas ,Cristina Puig-Saus

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

伊匹木单抗联合或不联合纳武利尤单抗治疗PD-1或PD-L1阻断疗法无效的转移性黑色素瘤:一项随机II期试验

VanderWalde, Ari; Bellasea, Shay L; Kendra, Kari L; Khushalani, Nikhil I; Campbell, Katie M; Scumpia, Philip O; Kuklinski, Lawrence F; Collichio, Frances; Sosman, Jeffrey A; Ikeguchi, Alexandra; Victor, Adrienne I; Truong, Thach-Giao; Chmielowski, Bartosz; Portnoy, David C; Chen, Yuanbin; Margolin, Kim; Bane, Charles; Dasanu, Constantin A; Johnson, Douglas B; Eroglu, Zeynep; Chandra, Sunandana; Medina, Egmidio; Gonzalez, Cynthia R; Baselga-Carretero, Ignacio; Vega-Crespo, Agustin; Garcilazo, Ivan Perez; Sharon, Elad; Hu-Lieskovan, Siwen; Patel, Sapna P; Grossmann, Kenneth F; Moon, James; Wu, Michael C; Ribas, Antoni

Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade

PD-1 阻断转基因过继细胞疗法导致 NY-ESO-1 表达丧失,进而导致免疫疗法耐药性

Luke Frankiw #, Arun Singh #, Cole Peters, Begoña Comin-Anduix, Beata Berent-Maoz, Mignonette Macabali, Kiana Shammaie, Crystal Quiros, Paula Kaplan-Lefko, Ignacio Baselga Carretero, Antoni Ribas, Theodore Scott Nowicki

Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy

输注产品中的TNFα、Th2和STAT3活性与转基因T细胞受体细胞疗法的临床反应相关

Theodore S Nowicki ,Cole W Peters ,Crystal Quiros ,Conner K Kidd ,Moe Kawakami ,Alexandra M Klomhaus ,Ignacio Baselga-Carretero ,Paula Kaplan-Lefko ,Mignonette H Macabali ,Ivan Perez Garcilazo ,Beata Berent-Maoz ,Begoña Comin-Anduix ,Antoni Ribas

A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

一项针对HER2阴性乳腺癌的新辅助治疗方案——纳武利尤单抗、伊匹木单抗联合病灶内溶瘤病毒疗法的初步研究

Nguyen, Vina P; Campbell, Katie M; Nowicki, Theodore S; Elumalai, Nila; Medina, Egmidio; Baselga-Carretero, Ignacio; DiNome, Maggie L; Chang, Helena R; Oseguera, Denise K; Ribas, Antoni; Glaspy, John A

Remodeling of the tumor microenvironment through PAK4 inhibition sensitizes tumors to immune checkpoint blockade

通过抑制 PAK4 重塑肿瘤微环境,使肿瘤对免疫检查点阻断敏感

Gabriel Abril-Rodríguez, Davis Y Torrejon, Daniel Karin, Katie M Campbell, Egmidio Medina, Justin D Saco, Mildred Galvez, Ameya S Champhekar, Ivan Perez-Garcilazo, Ignacio Baselga-Carretero, Jas Singh, Begoña Comin-Anduix, Cristina Puig-Saus, Antoni Ribas

PAK4 inhibition improves PD-1 blockade immunotherapy

PAK4 抑制可改善 PD-1 阻断免疫疗法

Gabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, Jesse M Zaretsky, Theodore S Nowicki, Jennifer Tsoi, Cristina Puig-Saus, Ignacio Baselga-Carretero, Egmidio Medina, Michael J Quist, Alejandro J Garcia, William Senapedis, Erkan Baloglu, Anusha Kalbasi, Gardenia Cheung-Lau, Beata Berent-Maoz, Begoñ